verified
Verified Information • Last Updated Mar 2026
Pillar #1: Drug Development - From Bench to Bedside
Have you ever taken over the counter or prescription drug? Are you curious about how these drugs are developed, approved and brought to the market? We begin by providing an overview of drug development and approval process and the role regulatory agencies, such as the US Food and Drug Administration, play in the approval process. We discuss phases of clinical trials – phases 1, 2, 3 and 4 – to evaluate efficacy and safety of drug products, along with case studies. We define pharmacoepidemiology – a scientific discipline to study use, safety and effectiveness of medical products and interventions – and the role it plays throughout the drug life cycle with relevant case studies. We also discuss how pharmacoepidemiology informs regulatory, policy and clinical decisions. Finally, we provide high-level overview of essential tools – study protocols, data sources, study designs and analysis – to conduct pharmacoepidemiologic studies.
Duration
5 Months
Institution
Johns Hopkins University
Format
Online
Eligibility Criteria
school
Academic Foundation
A recognized Bachelor’s degree or high school equivalent required for admission into Johns Hopkins University.
language
Language Proficiency
English proficiency required. IELTS, TOEFL, or standard medium-of-instruction certificates accepted.
Detailed Fees Breakdown
Base Tuition Fee
$265
Total Est. Investment
$265
Scholarships and early-bird waivers may apply. Contact admissions for exact institutional fees.
Academic Trajectory
Program Outcome
Graduates of the Pillar #1: Drug Development - From Bench to Bedside program at Johns Hopkins University are equipped with global perspectives, ready to excel in international markets and top-tier career opportunities.